A Nonrandomized Phase Ii Trial Of Sorafenib (S) And Everolimus (E) In Unresectable Metastatic Osteosarcoma (Ost) Patients (Pts) Relapsed After Standard Chemotherapy.Giovanni Grignani,Emanuela Palmerini,Virginia Ferraresi,Sebastian Dorin Asaftei,Lorenzo D'Ambrosio,Ymera Pignochino,Annamaria Nuzzo,Marco Gambarotti,Emanuela Marchesi,Roberto Biagini,Angela Tamburini,Rossella Bertulli,Paolo G Casali,Franca Fagioli,Piero Picci,Stefano Ferrari,Massimo AgliettaJOURNAL OF CLINICAL ONCOLOGY（2014）引用 3|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
